Benevolent Capital Partners – Private Equity Investment Firm

The Benevolent Difference

Benevolent Capital is a private equity investment firm focused on creating value by making investments into early-stage growth companies.

Benevolent Capital approaches its relationship with its investors and portfolio partners as “benevolent.” Unlike traditional funds, we do not charge our investors a management fee and provide exceptional preferred returns to our limited partners before taking a promotion on our investments. In short, we don’t do well, unless or until our investors do well.

Whether through a seat on the board, a role in company governance, or an advisory relationship, Benevolent Capital is an engaged investor, seeking to add value and empower the companies in which we invest while offering our limited partners a platform to realize returns before Benevolent receives any return on investment. Benevolent structures its investments through special purpose vehicles that exclude management fees and presents unique opportunities to invest in early-stage growth companies. We have worked with companies at most stages of financing and continue to broaden our network.

Benevolent Capital is a private equity investment firm focused on creating value by making investments into early-stage growth companies.

Benevolent Capital approaches its relationship with its investors and portfolio partners as “benevolent.” Unlike traditional funds, we do not charge our investors a management fee, and provide exceptional preferred returns to our limited partners before taking a promotion on our investments. In short, we don’t do well, unless or until our investors do well.

Whether through a seat on the board, a role in company governance, or an advisory relationship, Benevolent Capital is an engaged investor, seeking to add value and empower the companies in which we invest while offering our limited partners a platform to realize returns before Benevolent receives any return on an investment. Benevolent structures its investments through special purpose vehicles that exclude management fees and presents unique opportunities to invest in early-stage growth companies. We have worked with companies at most stages of financing and continue to broaden our network.

Portfolio

Sports Franchises

We believe in the social and economic impact inherent in professional sports investments, coupled with the exceptional un-correlated equity appreciation that ownership of the right sports teams, in the right leagues and geographies will provide.

Read The Latest News

Sports Franchises

We believe in the social and economic impact inherent in professional sports investments, coupled with the exceptional un-correlated equity appreciation that ownership of the right sports teams, in the right leagues and geographies will provide.

Read The Latest News

Real Estate

We focus on co-investments and syndication in professional sports anchored real estate development & joint-ventures with best-in-class partners.

Read The Latest News

Real Estate

We focus on co-investments and syndication in professional sports anchored real estate development & joint-ventures with best-in-class partners.

Read The Latest News

Private Equity

We invest in profitable, growing small-to-mid market companies with strong business models, records of revenue and earnings growth and the leadership capable of sustaining that growth

Read The Latest News

Private Equity

We invest in profitable, growing small-to-mid market companies with strong business models, records of revenue and earnings growth and the leadership capable of sustaining that growth

Read The Latest News

Venture Capital

We focus on partnering with dynamic, scalable platforms which have unique placement within growth industries.

Read The Latest News

Venture Capital

We focus on partnering with dynamic, scalable platforms which have unique placement within growth industries.

Read The Latest News

About Us

Benevolent Capital was founded in 2005 by Brett and Grant Johnson as their Family Office.

From this initial launch, our platform has expanded to include a world-class group of partners, associates and investors, and our portfolio now spans catalytic investments in venture capital, private equity, real estate development and a diverse collection of global professional soccer franchises.

Before creating a private equity firm, we were operating executives of companies ranging from start-ups to an international company with over $500 million in revenues. Our wide range of experience from managing successful companies, to completing management buyouts, acquisitions, and a wide variety of debt and equity investments totaling over $4 billion enables us to truly partner with the entrepreneurs and management teams of our portfolio companies and provide hands on support and guidance towards realizing their full potential.

Benevolent has a proven track record of successful investments. Most notably, our $200k investment in seed capital for Enzymatics, a biotech firm later ultimately acquired by Invitae (NASDAQ: NVTA), has yielded over $30MM in total returns for Benevolent’s investors.

Benevolent Capital was founded in 2005 by Brett and Grant Johnson as their Family Office.

From this initial launch, our platform has expanded to include a world-class group of partners, associates and investors, and our portfolio now spans catalytic investments in venture capital, private equity, real estate development and a diverse collection of global professional soccer franchises.

Before creating a private equity firm, we were operating executives of companies ranging from start-ups to an international company with over $500 million in revenues. Our wide range of experience from managing successful companies, to completing management buyouts, acquisitions, and a wide variety of debt and equity investments totaling over $4 billion enables us to truly partner with the entrepreneurs and management teams of our portfolio companies and provide hands on support and guidance towards realizing their full potential.

Benevolent has a proven track record of successful investments. Most notably, our $200k investment in seed capital for Enzymatics, a biotech firm later ultimately acquired by Invitae (NASDAQ: NVTA), has yielded over $30MM in total returns for Benevolent’s investors.